Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05947981
Other study ID # MS-206-2022
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2023
Est. completion date January 31, 2024

Study information

Verified date March 2024
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

With this study, we aim to compare the efficacy of pre-operative dextrose-containing fluid infusion with other fluid for the prevention of PONV in middle ear surgeries.


Description:

We hypothesized that maintenance of stable level of blood glucose in addition to adequate hydration through preoperative intravenous dextrose 5% infusion will have a rule in decreasing the incidence and severity of PONV; as it reduces insulin resistance and decreases gastric acid secretion; which may contribute to PONV.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date January 31, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - ASA physical status I and ll. - Patients undergoing middle ear surgeries, mastoidectomy, or tympanoplasty Exclusion Criteria: - history of dependence or use of antiemetics - history of motion sickness - presence of psychiatric illness - pregnant and lactating women - cardiovascular disorders (Ischemic heart diseases, congestive heart failure and valvular diseases) - Diabetic patients

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Dextrose 5%, normal saline
Decrease fasting hours

Locations

Country Name City State
Egypt Faculty of Medicine- Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary PONV incidence 24 hours
See also
  Status Clinical Trial Phase
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04622618 - Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting Early Phase 1
Completed NCT03599427 - Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy Phase 4
Recruiting NCT05975385 - Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy N/A
Recruiting NCT04589429 - Adding Nalbuphine for Control of Intrathecal Morphine Pruritus Phase 2
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Recruiting NCT06137976 - Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy N/A
Not yet recruiting NCT06114277 - The Relationship Between Intraoperative ETCO2 Levels and Postoperative Pain and Nausea-Vomiting
Recruiting NCT04618146 - Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. N/A
Active, not recruiting NCT03645239 - Post-operative Emesis and Pain Outcomes After Cesarean Delivery
Completed NCT04610398 - Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy Phase 3
Completed NCT03130218 - Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients N/A
Completed NCT03577496 - Does Aromatherapy Decrease Postoperative Nausea and Vomiting? N/A
Recruiting NCT06151912 - The Effect of Staple Line Reinforcement Procedures on Postoperative Nausea and Vomiting in Sleeve Gastrectomy N/A
Recruiting NCT04762381 - Dexamethasone and Robotic-assisted Hysterectomy N/A
Not yet recruiting NCT04442568 - Impact of ERAS in LSG N/A
Completed NCT03727607 - TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery Phase 2
Recruiting NCT06110416 - Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient N/A
Not yet recruiting NCT06137924 - Intraoperative Autonomic Neural Blockade Phase 3
Recruiting NCT06022705 - Evaluation of the Effect of APFEL Risk Score and Fasting Periods on Postoperative Nausea and/or Vomiting